Rchr
J-GLOBAL ID:201801001064359171   Update date: Jul. 17, 2020

Tahara Makoto

タハラ マコト | Tahara Makoto
Research field  (1): Hematology and oncology
Papers (127):
  • Chia-Jui Yen, Naomi Kiyota, Nobuhiro Hanai, Shunji Takahashi, Tomoya Yokota, Shigemichi Iwae, Yasushi Shimizu, Ruey-Long Hong, Masahiro Goto, Jin-Hyoung Kang, Wing Sum Kenneth Li, Robert L Ferris, Maura Gillison, Toshimitsu Endo, Vijayvel Jayaprakash, Makoto Tahara. Two-year follow-up of a randomized phase III clinical trial of nivolumab vs. the investigator's choice of therapy in the Asian population for recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141). Head & neck. 2020
  • Hisham Mehanna, Danny Rischin, Stuart J Wong, Vincent Gregoire, Robert Ferris, John Waldron, Quynh-Thu Le, Martin Forster, Maura Gillison, Sarbani Laskar, Makoto Tahara, Amanda Psyrri, Jan Vermorken, Sandro Porceddu. De-Escalation After DE-ESCALATE and RTOG 1016: A Head and Neck Cancer InterGroup Framework for Future De-Escalation Studies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2020. JCO2000056
  • Jean-Pascal Machiels, Yungan Tao, Barbara Burtness, Makoto Tahara, Lisa Licitra, Danny Rischin, John Waldron, Christian Simon, Vincent Gregoire, Kevin Harrington, Gustavo Vasconcelos Alves, Iane Pinto Figueiredo Lima, Yoann Pointreau, Brett G M Hughes, Sercan Aksoy, Marcin Hetnal, Joy Y Ge, Holly Brown, Jonathan Cheng, Behzad Bidadi, Lillian L Siu. Pembrolizumab given concomitantly with chemoradiation and as maintenance therapy for locally advanced head and neck squamous cell carcinoma: KEYNOTE-412. Future oncology (London, England). 2020. 16. 18. 1235-1243
  • David S Hong, Steven G DuBois, Shivaani Kummar, Anna F Farago, Catherine M Albert, Kristoffer S Rohrberg, Cornelis M van Tilburg, Ramamoorthy Nagasubramanian, Jordan D Berlin, Noah Federman, Leo Mascarenhas, Birgit Geoerger, Afshin Dowlati, Alberto S Pappo, Stefan Bielack, François Doz, Ray McDermott, Jyoti D Patel, Russell J Schilder, Makoto Tahara, Stefan M Pfister, Olaf Witt, Marc Ladanyi, Erin R Rudzinski, Shivani Nanda, Barrett H Childs, Theodore W Laetsch, David M Hyman, Alexander Drilon. Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials. The Lancet. Oncology. 2020. 21. 4. 531-540
  • Takashi Maruo, Sadamoto Zenda, Takeshi Shinozaki, Toshifumi Tomioka, Wataru Okano, Minoru Sakuraba, Makoto Tahara, Ryuichi Hayashi. Comparison of salvage surgery for recurrent or residual head and neck squamous cell carcinoma. Japanese journal of clinical oncology. 2020. 50. 3. 288-295
more...
MISC (80):
  • 田原信, 清田尚臣, 丹生健一, 星野智洋, 飯田修, 林隆一. 再発又は遠隔転移を有する頭頸部がんの患者を対象としたニボルマブの安全性及び有効性の検討. 頭頸部癌. 2019. 45. 2. 143
  • 茂木厚, 全田貞幹, 中村直樹, 中村匡希, 北條秀博, 奥村真之, 林隆一, 田原信. 中咽頭癌に対するIMRTにおける標的設定方針が,標的体積ならびにリスク臓器線量に与える影響. 頭頸部癌. 2019. 45. 2. 135
  • 篠崎剛, 林隆一, 富岡利文, 岡野渉, 田原信, BIEL Merrill. Phase I study of RM-1929 and photoimmunotherapy in Japanese patients with head & neck cancer. 頭頸部癌. 2019. 45. 2. 143
  • 小川 武則, 中目 亜矢子, 榎田 智弘, 本間 明宏, 大上 研二, 南 修司郎, 岩江 信法, 清水 康, 槇 大輔, 上田 百合, 藤澤 孝夫, 茂木 厚, 野村 尚吾, 香取 幸夫, 田原 信. 頭頸部癌の薬物治療の今後の展開 局所進行頭頸部扁平上皮癌に対する導入化学療法. 頭頸部癌. 2019. 45. 2. 114-114
  • Shunji Takahashi, Naomi Kiyota, Tomoko Yamazaki, Naoko Chayahara, Kenji Nakano, Lina Inagaki, Kazuhisa Toda, Tomohiro Enokida, Hironobu Minami, Yoshinori Imamura, Naoki Fukuda, Tatsuya Sasaki, Takuya Suzuki, Hiroki Ikezawa, Corina E Dutcus, Makoto Tahara. A Phase II study of the safety and efficacy of lenvatinib in patients with advanced thyroid cancer. Future oncology (London, England). 2019. 15. 7. 717-726
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page